What is MiniMed Group 's SG&A?

MiniMed Group (MMED) reported SG&A of $309M in Q1 2026.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

MiniMed Group MMED SG&A

SG&A at other companies

MYR GroupMYRG

$69.42M+11.0%

RepligenRGEN

$76.54M+8.2%

GriffonGFF

$104.64M-2.6%

Power IntegrationsPOWI

$24.44M-10.9%

Universal Technical InstituteUTI

$103.63M+17.6%

DucommunDCO

$40.51M-10.1%

Other financials

Income statement

See full

Revenue$790.0M+15.0%

Gross profit$362.0M-8.4%

Operating income-$100.0M-576%

Net income-$119.0M-1,090%

EPS (diluted)-$0.47-1,075%

Balance sheet

See full

Cash & equivalents$10.0M0.0%

Total debt$61.0M—

Total equity$3.5B-0.7%

Total assets$4.3B—

Cash flow

See full

Operating cash flow-$27.0M-147%

CapEx$167.0M+22.8%

Free cash flow-$194.0M-146%

Valuation

See full

Market cap$3.86B—

Returns & leverage

See full

Debt / equity0×—

Current ratio1.6×—

Where this comes from

Reported directly by MiniMed Group in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: MiniMed Group ’s 10-Q, filed April 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiniMed Group 's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MiniMed Group 's SG&A?: MiniMed Group (MMED) reported SG&A of $309M in Q1 2026.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.